Does Race Impact Mortality Rates in Patients with End-stage Renal Disease?
“Among children with end-stage kidney disease, death risk is much lower for those who receive a kidney transplant after their diagnosis than for those who remain on dialysis.”
Philadelphia – During a press conference at Kidney Week 2011, Sandra Amaral, MD, MHS, Children’s Hospital of Philadelphia, stressed how important it is for pediatricians and pediatric nephrologists to promote the process of kidney transplant to happen as soon as possible in children who are diagnosed with ESRD. She explained evidence suggests that through a transplant, it will improve the mortality and morbidity in the children compared to being on dialysis; children on dialysis have a much higher risk of death than those who receive a kidney transplant.
Amaral shared the results of a study in which she and her fellow researchers evaluated mortality rates after new diagnoses of end-stage renal disease (ESRD) to see if they varied by race. A secondary focus of the study was “to examine whether insurance status and/or neighborhood poverty influenced racial differences” (Amaral, PowerPoint). Additionally, Amaral and her colleagues sought to answer two questions:
Upon reviewing the results, Amaral et al. found that the patients who died were most likely to be black children with public insurance and living in poorer neighborhoods than Hispanics and whites. In fact, the Hispanic population had the lowest risk of mortality regardless of insurance status. When comparing the insurance status between blacks and whites, the data showed that uninsured blacks had a 78% higher mortality risk than uninsured whites.
Based on these findings, the Amaral et al. learned the following:
- Sandra Amaral, MD, MHS, Children’s Hospital of Philadelphia
Philadelphia – During a press conference at Kidney Week 2011, Sandra Amaral, MD, MHS, Children’s Hospital of Philadelphia, stressed how important it is for pediatricians and pediatric nephrologists to promote the process of kidney transplant to happen as soon as possible in children who are diagnosed with ESRD. She explained evidence suggests that through a transplant, it will improve the mortality and morbidity in the children compared to being on dialysis; children on dialysis have a much higher risk of death than those who receive a kidney transplant.
Amaral shared the results of a study in which she and her fellow researchers evaluated mortality rates after new diagnoses of end-stage renal disease (ESRD) to see if they varied by race. A secondary focus of the study was “to examine whether insurance status and/or neighborhood poverty influenced racial differences” (Amaral, PowerPoint). Additionally, Amaral and her colleagues sought to answer two questions:
- Why don’t patients get transplanted?
- Who are those patients who are remaining on dialysis and having this higher risk of death?
Upon reviewing the results, Amaral et al. found that the patients who died were most likely to be black children with public insurance and living in poorer neighborhoods than Hispanics and whites. In fact, the Hispanic population had the lowest risk of mortality regardless of insurance status. When comparing the insurance status between blacks and whites, the data showed that uninsured blacks had a 78% higher mortality risk than uninsured whites.
Based on these findings, the Amaral et al. learned the following:
- Health insurance may impact the mortality rate
- There was no significant difference by race in the neighborhood
- Need more studies to confirm their findings
Comment(s)
Your comments are valuable to us. Thank you.
Sorry, you must be logged in and registered to post a comment.
Related Articles

American Journal of Managed Care
American Journal of Pharmacy Benefits
HCPLive
ONCLive
OTCGuide
Pharmacy Times
Physician's Money Digest
American Journal of Pharmacy Benefits
HCPLive
ONCLive
OTCGuide
Pharmacy Times
Physician's Money Digest
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747
Copyright HCPLive 2006-2011
Intellisphere, LLC. All Rights Reserved.
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747
Copyright HCPLive 2006-2011
Intellisphere, LLC. All Rights Reserved.

